Endovenous laser ablation of the great saphenous vein in patients with von willebrand disease

Abstract

Introduction Patients with von Willebrand disease have a high risk of bleeding during the surgical treatment of varicose veins. Endovenous laser ablation (EVLA) of the great saphenous vein (GSV) is a minimally invasive treatment for saphenofemoral junction incompetence. Th e number of complications and relapse rate of EVLA are lower than in those of conventional surgical treatment. Case presentation A patient with great saphenous vein insuffi ciency, von Willebrand disease and hypofi brinogenemia successfully underwent endovenous laser ablation. Replacement therapy with cryoprecipitate was administered preoperatively and postoperatively. Th e surgical procedure and postoperative course were unremarkable. Conclusion In patients with von Willebrand disease and other coagulation disorders, endovenous laser ablation is a safe and effective treatment. Th e use of minimally invasive treatment, the adequate correction of haemostasis, and close cooperation between the haematologist, anaesthesiologist and endovascular surgeon reduce the risk of bleeding.